CIK 0001723128 · Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- Phone
- (908) 947-3120
- Former names
- Atlas Holdings, Inc.
- 4 Option exercise Director acquired 34,819 shares (option exercise)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Shares withheld for taxes Co-CEO gave up 361,980 shares (to pay taxes)
- 4 Shares withheld for taxes President & Co-CEO gave up 350,978 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Legal Officer gave up 185,641 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President & CFO gave up 306,583 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 275,307 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 255,109 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 50,000 shares at $11.72 ($586,000)
- 4 Open-market sale Executive Vice President sold 131,856 shares at $11.92 ($1,571,724)
- 4 Open-market sale Director sold 32,000 shares at $9.23 ($295,360)
- 4 Open-market sale Executive Vice President sold 120,832 shares at an average $9.65 ($1,166,223)
- 4 Open-market sale Executive Vice President sold 279,244 shares at $9.38 ($2,619,309)
Page 2 of 18 · 351 filings